It appears the medical research field has forgotten this basic tenet of science:
It's almost as if it isn't science at all, but rather advertising, where the target audience is a government agency that gives the company permission to transfer the product to their other advertising division who then advertise it to doctors and the public. What percentage of these clinical trials are trials of something not destined to produce wealth for an organization if the results of the trial are positive? When a wealth generating organization approves expenditure of the large amount of money to do a clinical trial, I'm sure it also adds extra management, or transfers management of the research so as to help the results of the trial be more profitable than just doing science ever could be. I'm thankful that this requirement to register these trials exists.
For most specific problems thrown at supercomputers, you can go 30 times faster with a custom hardware architecture baked into silicon
Perhaps that's what they should do. Make a robotic silicon wafer fabrication facility part of the computer. After being given a task requiring a new architecture, it creates the architecture it needs and augments itself. I'm sure for less than the cost of the F-35 program, a universally tasking self augmenting supercomputer could be made to happen.
Nothing succeeds like the appearance of success. -- Christopher Lascl